oncosec medical inc (ONCS) Key Developments
OncoSec Medical Incorporated - Shareholder/Analyst Call
Jul 23 15
Annual Shareholder Meeting
OncoSec Medical Inc. Appoints Joann V. Lofgren as Vice President of Market Development
Jul 6 15
OncoSec Medical Inc. announced the appointment of Joann V. Lofgren to the newly created position of Vice President of Market Development, effective July 6, 2015. In this role, Ms. Lofgren will be responsible for evaluating, designing, and executing on the company's market and product development strategy for all therapeutic products. Most recently Lofgren served as the Marketing Director for Hansen Medical, where she developed and implemented strategic plans to grow the sales of robotic systems and catheters in the $1.5 billion global electrophysiology ablation market.
Oncosec Medical Inc. Announces Executive Changes
Jun 25 15
OncoSec Medical Inc. announced the appointment of Richard B. Slansky as the company's Chief Financial Officer, with effect from July 6, 2015. Mr. Slansky is responsible for leading financial operations and activities for OncoSec as well as managing financial plans and budgets. Veronica Vallejo, the current Chief Financial Officer of OncoSec, resigned from her position effective June 24, 2015 to pursue other opportunities. Mr. Slansky brings more than 25 years of senior management experience to OncoSec and has a proven track record managing financial investments for life science and technology companies. Prior to joining OncoSec, Mr. Slansky held various financial leadership positions, including: Chief Financial Officer at GenMark Diagnostics Inc.; Chief Financial Officer at Digirad Corporation and President, Chief Financial Officer and Director at SpaceDev Inc.
OncoSec Medical Incorporated(NasdaqCM:ONCS) added to NASDAQ Composite Index
Jun 25 15
OncoSec Medical Incorporated has been added to Nasdaq Composite Index.
OncoSec Medical Incorporated, Annual General Meeting, Jul 31, 2015
Jun 17 15
OncoSec Medical Incorporated, Annual General Meeting, Jul 31, 2015., at 09:00 Pacific Standard Time. Location: Lighthouse Room. Agenda: To elect four directors to Board of Directors to serve for a term of one year or until their successors are duly elected and qualified; to ratify the appointment of Mayer Hoffman McCann P.C. as the company's independent registered public accounting firm for the fiscal year ending July 31, 2015; to amend the 2011 Stock Incentive Plan to increase the shares reserved for issuance there under and increase the annual per person limit on stock options, stock appreciation rights, restricted stock and restricted stock units that are intended to qualify for exclusion from the federal tax deduction limitation under Section 162(m) of the Internal Revenue Code; and to transact other business as may properly come before the annual meeting or any adjournment or postponement thereof.